Revised Research Question:
To what degree does Intellectual property law dictate and drive pharmaceutical industry and does this truly inspire innovation rather than inhibit it? Additionally who benefits the most from IP protection in pharmaceutical industry, corporations or the public domain?
No comments:
Post a Comment